본문 바로가기
KERD
논문KCI 등재

Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류내과학

참고문헌 (10)

  1. Sugano K, "Kyoto global consensus report on Helicobacter pylori gastritis", Gut, 64, pp.1353~1367 (2015)
  2. Malfertheiner P, "European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI", Florence consensus report, 2022, ~
  3. 김태호, "헬리코박터 제균치료 시 프로톤펌프억제제 식전 투여가 더 좋을까?", Korean Journal of Helicobacter Upper Gastrointestinal Research, 18(2), pp.79~81 (2018), 대한상부위장관ㆍ헬리코박터학회[DOI]
  4. Tae Ho Kim, "Comparison of 7- and 14-Day Eradication Therapy for Helicobacter pylori with First- and Second-Line Regimen: Randomized Clinical Trial", Journal of Korean Medical Science, 35(5), pp.1~9 (2020), 대한의학회[DOI]
  5. Murakami K, "Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication : a phase III, randomised, double-blind study", Gut, 65, pp.1439~1446 (2016)
  6. Simadibrata DM, "A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases : a systematic review and meta-analysis", J Gastroenterol Hepatol, 37, pp.2217~2228 (2022)
  7. Kambara H, "Safety profile of vonoprazan compared with proton pump inhibitors : insight from a pharmacovigilance study", Pharmazie, 75, pp.527~530 (2020)
  8. Zhang M, "Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials", Clinics(Sao Paulo), 77, pp.100058~ (2022)
  9. Ghim JL, "Pharmacokinetics and pharmacodynamics of tegoprazan coadministered with amoxicillin and clarithromycin in healthy subjects", J Clin Pharmacol, 61, pp.913~922 (2021)
  10. Beom Jin Kim, "Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea", Gut and Liver, 13(5), pp.531~540 (2019), 거트앤리버 소화기연관학회협의회[DOI]

관련 논문AI추천

Role of Tegoprazan in Helicobacter pylori Eradication Therapy이진거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제4호Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication?Maeda Shin, Sue Soichiro거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제6호Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot StudyChoi Il Ju, Hong Su Jin, Jeon Seong Woo, Kim Gwang Ha, Kim Jae Gyu, Park Jae Yong, Shin Sung Kwan거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제5호Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradicationDong Wook Lee, Hui Jin Bae, Ji Hey Park, Seong Woo Jeon, Su Youn Nam, Yong Hwan Kwon대한내과학회 · The Korean Journal of Internal Medicine2023 · 제38권 제4호Considering the Long-Conflicting Topic of Empirical or Nonconventional Helicobacter pylori Eradication RegimensKountouras Jannis거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제4호Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial김나영, 김정목, 김지현, 백광호, 심기남, 이용찬, 이항락, 정현수, 정혜경, Choi Yoon Jin, Chun Hoon Jai, Jang Jae Young, Kim Byung-Wook, Kim Jin Il, Kim Kyoung Oh, Kim Sang Gyun, Ko Kwang Hyun, Lee Hyuk, Lim Yun Jeong, Moon Jeong Seop, Son Byoung Kwan거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제4호

이 간행물의 다른 논문 (18건)